U.S. Court of Appeals for the Federal Circuit, 2025

Pacira Pharmaceuticals, Inc. v. Evenus Pharmaceuticals Laboratories Inc.

Pacira Pharmaceuticals, Inc. v. Evenus Pharmaceuticals Laboratories Inc.
U.S. Court of Appeals for the Federal Circuit · Decided April 10, 2025
Pacira Pharmaceuticals, Inc. v. Evenus Pharmaceuticals Laboratories Inc.

Opinion

Case: 24-2334 Document: 19 Page: 1 Filed: 04/10/2025

NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________ PACIRA PHARMACEUTICALS, INC., PACIRA BIOSCIENCES, INC.,

Plaintiffs-Appellants v.

EVENUS PHARMACEUTICALS LABORATORIES

INC., JIANGSU HENGRUI PHARMACEUTICALS CO., LTD., FRESENIUS KABI USA, LLC, Defendants-Appellees ______________________

2024-2334 ______________________ Appeal from the United States District Court for the District of New Jersey in No. 2:21-cv-19829-MCA-JRA, 2:22-cv-00718-MCA-JRA, Judge Madeline Cox Arleo. ______________________ ORDER

The parties having so agreed, it is ordered that:

(1) The proceeding is DISMISSED under Fed. R. App. P. 42 (b).

Case: 24-2334 Document: 19 Page: 2 Filed: 04/10/2025

2 PACIRA PHARMACEUTICALS, INC. V. EVENUS PHARMACEUTICALS LABORATORIES INC.

(2) Each side shall bear their own costs.

FOR THE COURT

April 10, 2025

Date

ISSUED AS A MANDATE: April 10, 2025

Case-law data current through September 30, 2026. Source: CourtListener bulk data.